P. Drevot

Membrane rafts and signaling by the multichain immune recognition receptors.

C. Langlet, A. Bernard, P. Drevot, 2000, Current opinion in immunology.

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

J. Mackey, N. Robert, V. Valero, 2016 .

TCR signal initiation machinery is pre‐assembled and activated in a subset of membrane rafts

J. Chauvin, C. Langlet, Xiao-jun Guo, 2002, The EMBO journal.

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.

M. Buyse, G. Sauter, J. Mackey, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.

M. Buyse, G. Sauter, J. Mackey, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA

L. van der Hoek, R. Laufer, M. S. van der Knaap, 2023, Annals of clinical and translational neurology.